- 米国企業
- Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc.AMPH
| 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 |
---|
Cash and cash equivalents | 68 | 66 | 72 | 66 | 86 | 74 | 93 | 126 | 156 | 144 |
---|
Restricted cash | - | - | - | - | - | - | 2 | 0 | 0 | 0 |
---|
Short-term investments | - | - | 1 | 3 | 3 | 12 | 13 | 10 | 20 | 113 |
---|
Restricted Investments, Current | - | - | 1 | - | - | 2 | 2 | 2 | 2 | 2 |
---|
Accounts receivable, net | 23 | 33 | 27 | 36 | 52 | 45 | 66 | 79 | 89 | 115 |
---|
Inventories | 82 | 71 | 80 | 64 | 69 | 111 | 97 | 93 | 104 | 106 |
---|
Income Tax Refund And deposits | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 1 |
---|
Prepaid expenses and other assets | 4 | 4 | 3 | 10 | 5 | 10 | 7 | 7 | 8 | 9 |
---|
Total current assets | 198 | 176 | 184 | 188 | 220 | 255 | 280 | 318 | 378 | 490 |
---|
Property, plant, and equipment | 138 | 142 | 153 | 185 | 210 | 234 | 260 | 244 | 238 | 283 |
---|
Finance lease right-of-use assets | - | - | - | - | - | 1 | 1 | 0 | 1 | 1 |
---|
Operating lease right-of-use assets | - | - | - | - | - | 19 | 20 | 27 | 26 | 32 |
---|
Equity Method Investments | - | - | - | - | - | - | - | 4 | 2 | - |
---|
Investment in unconsolidated affiliate | - | - | - | - | - | - | - | - | - | 1 |
---|
Goodwill and intangible assets, net | 43 | 40 | 50 | 45 | 42 | 41 | 41 | 39 | 37 | 613 |
---|
Other assets | 4 | 5 | 9 | 9 | 10 | 11 | 5 | 17 | 21 | 26 |
---|
Long-term investments | - | - | - | - | - | - | - | - | - | 15 |
---|
Deferred tax assets | - | - | - | - | - | 26 | 25 | 22 | 39 | 53 |
---|
Other assets | 4 | 5 | 9 | 9 | 10 | 11 | 5 | 17 | 21 | 26 |
---|
Total assets | 389 | 390 | 428 | 455 | 514 | 587 | 631 | 672 | 742 | 1,513 |
---|
Deferred tax assets | - | - | - | - | - | 26 | 25 | 22 | 39 | 53 |
---|
Total assets | 389 | 390 | 428 | 455 | 514 | 587 | 631 | 672 | 742 | 1,513 |
---|
Accounts payable and accrued liabilities | - | - | - | 58 | 87 | 77 | 96 | 90 | 84 | 93 |
---|
Income taxes payable | 3 | 3 | 8 | 3 | 1 | 2 | 1 | 9 | 5 | 2 |
---|
Accrued payments for BAQSIMI | - | - | - | - | - | - | - | - | - | 126 |
---|
Current portion of long-term debt | 8 | 11 | 5 | 6 | 18 | 8 | 12 | 2 | 3 | 0 |
---|
Income taxes payable | 3 | 3 | 8 | 3 | 1 | 2 | 1 | 9 | 5 | 2 |
---|
Operating Lease, Liability, Current | - | - | - | - | - | 3 | 3 | 3 | 3 | 4 |
---|
Current portion of long-term debt | 8 | 11 | 5 | 6 | 18 | 8 | 12 | 2 | 3 | 0 |
---|
Total current liabilities | 63 | 60 | 61 | 67 | 107 | 90 | 112 | 104 | 95 | 225 |
---|
Operating Lease, Liability, Current | - | - | - | - | - | 3 | 3 | 3 | 3 | 4 |
---|
Total current liabilities | 63 | 60 | 61 | 67 | 107 | 90 | 112 | 104 | 95 | 225 |
---|
Accrued Income Taxes, Noncurrent | 0 | 0 | 1 | 1 | 0 | 3 | 5 | 7 | 7 | 6 |
---|
Long-term debt, net of current portion | 36 | 30 | 32 | 41 | 32 | 39 | 34 | 75 | 73 | 590 |
---|
Operating Lease, Liability, Noncurrent | - | - | - | - | - | 16 | 17 | 25 | 24 | 30 |
---|
Deferred tax liabilities | - | - | - | - | - | 1 | 1 | 1 | 0 | - |
---|
Other long-term liability | - | 2 | 2 | 7 | 9 | 9 | 13 | 16 | 15 | 23 |
---|
Total liabilities | 108 | 95 | 98 | 117 | 149 | 159 | 183 | 226 | 213 | 873 |
---|
Preferred Stock, Value | - | - | - | - | - | - | - | - | - | - |
---|
Common Stock, Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 221 | 248 | 283 | 314 | 344 | 367 | 410 | 422 | 455 | 486 |
---|
Retained earnings | 63 | 60 | 71 | 76 | 67 | 116 | 118 | 180 | 272 | 409 |
---|
Accumulated other comprehensive loss | -2 | -2 | -5 | -2 | -4 | -5 | -4 | -7 | -9 | -8 |
---|
Treasury stock | 0 | 10 | 20 | 51 | 75 | 98 | 122 | 150 | 190 | 247 |
---|
Total equity | - | - | - | - | 364 | 428 | 449 | 446 | 529 | 639 |
---|
Total liabilities and stockholders' equity | 389 | 390 | 428 | 455 | 514 | 587 | 631 | 672 | 742 | 1,513 |
---|